Variant report

Variant	nsv825000
Chromosome Location	chr9:100613121-100618319
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:197)
CpG islands
(count:794)
Chromatin interactive
region (count:3)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:197 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr9:100614820-100615239	H1-hESC	embryonic stem cell:	n/a	n/a
2	BRCA1	chr9:100616407-100616413	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr9:100616331-100616473	Hela-S3	cervix:	n/a	n/a
4	CHD2	chr9:100616044-100616681	Hela-S3	cervix:	n/a	n/a
5	CHD2	chr9:100616408-100616611	H1-hESC	embryonic stem cell:	n/a	n/a
6	CREB1	chr9:100616132-100616744	A549	lung:	n/a	n/a
7	CTBP2	chr9:100616289-100618535	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTBP2	chr9:100613864-100616060	H1-hESC	embryonic stem cell:	n/a	n/a
9	CTCF	chr9:100616320-100616470	HRE	kidney:	n/a	n/a
10	CTCF	chr9:100616340-100616490	HEEpiC	esophagus:	n/a	n/a
11	CTCF	chr9:100617700-100617850	HCFaa	heart:	n/a	n/a
12	CTCF	chr9:100616309-100616433	GM13977	blood:	n/a	n/a
13	CTCF	chr9:100616280-100616430	AG04449	skin:	n/a	n/a
14	CTCF	chr9:100616320-100616470	GM12871	blood:	n/a	n/a
15	CTCF	chr9:100616320-100616470	GM12869	blood:	n/a	n/a
16	CTCF	chr9:100616320-100616470	Hela-S3	cervix:	n/a	n/a
17	CTCF	chr9:100616320-100616470	SK-N-SH_RA	brain:	n/a	n/a
18	CTCF	chr9:100615960-100616110	BJ	skin:	n/a	n/a
19	CTCF	chr9:100616260-100616410	GM12873	blood:	n/a	n/a
20	CTCF	chr9:100616220-100616370	GM12874	blood:	n/a	n/a
21	CTCF	chr9:100616218-100616451	A549	lung:	n/a	n/a
22	CTCF	chr9:100616320-100616470	HMF	breast:	n/a	n/a
23	CTCF	chr9:100616320-100616470	GM12864	blood:	n/a	n/a
24	CTCF	chr9:100616236-100616462	A549	lung:	n/a	n/a
25	CTCF	chr9:100615541-100616886	A549	lung:	n/a	n/a
26	CTCF	chr9:100616300-100616450	NHEK	skin:	n/a	n/a
27	CTCF	chr9:100615880-100616030	SK-N-SH_RA	brain:	n/a	n/a
28	CTCF	chr9:100616275-100616412	SK-N-SH_RA	brain:	n/a	n/a
29	CTCF	chr9:100616272-100616460	GM12892	blood:	n/a	n/a
30	CTCF	chr9:100616280-100616430	GM12871	blood:	n/a	n/a
31	CTCF	chr9:100616280-100616430	GM12873	blood:	n/a	n/a
32	CTCF	chr9:100616340-100616490	GM12864	blood:	n/a	n/a
33	CTCF	chr9:100616300-100616450	HMEC	breast:	n/a	n/a
34	CTCF	chr9:100616520-100616670	RPTEC	kidney:	n/a	n/a
35	CTCF	chr9:100616304-100616452	HUVEC	blood vessel:	n/a	n/a
36	CTCF	chr9:100616236-100616495	Hela-S3	cervix:	n/a	n/a
37	CTCF	chr9:100616260-100616410	GM12866	blood:	n/a	n/a
38	CTCF	chr9:100616280-100616430	GM12874	blood:	n/a	n/a
39	CTCF	chr9:100616233-100616476	Fibrobl	skin:	n/a	n/a
40	CTCF	chr9:100616077-100616507	A549	lung:	n/a	n/a
41	CTCF	chr9:100616300-100616450	HUVEC	blood vessel:	n/a	n/a
42	CTCF	chr9:100616300-100616450	A549	lung:	n/a	n/a
43	CTCF	chr9:100616318-100616420	GM19240	blood:	n/a	n/a
44	CTCF	chr9:100616307-100616452	GM12878	blood:	n/a	n/a
45	CTCF	chr9:100616280-100616430	GM12870	blood:	n/a	n/a
46	CTCF	chr9:100616300-100616450	HEK293	kidney:	n/a	n/a
47	CTCF	chr9:100616293-100616407	Pancreas_OC	pancreas:	n/a	n/a
48	CTCF	chr9:100616320-100616470	BJ	skin:	n/a	n/a
49	CTCF	chr9:100616300-100616450	WERI-Rb-1	eye:	n/a	n/a
50	CTCF	chr9:100613920-100614070	WERI-Rb-1	eye:	n/a	n/a

(count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:100616607-100616657	HCF	heart:	n/a
2	chr9:100616607-100616657	HCF	heart:	n/a
3	chr9:100617370-100617420	HMEC	breast:	n/a
4	chr9:100615244-100615294	HRE	kidney:	n/a
5	chr9:100615244-100615294	BJ	skin:	n/a
6	chr9:100616607-100616657	BJ	skin:	n/a
7	chr9:100617710-100617760	BE2_C	brain:	n/a
8	chr9:100615357-100615407	A549	lung:	n/a
9	chr9:100615796-100615846	HNPCEpiC	eye:	n/a
10	chr9:100616469-100616519	RPTEC	kidney:	n/a
11	chr9:100613647-100613697	GM19239	blood:	n/a
12	chr9:100616607-100616657	Hepatocyte	liver:	n/a
13	chr9:100616469-100616519	Hepatocyte	liver:	n/a
14	chr9:100615084-100615134	NT2-D1	testis:	n/a
15	chr9:100614879-100614929	K562	blood:	n/a
16	chr9:100618041-100618091	AoSMC	blood vessel:	n/a
17	chr9:100617999-100618049	ovcar-3	ovarian:	n/a
18	chr9:100614879-100614929	AG04450	lung:	fetal
19	chr9:100616607-100616657	HL-60	blood:	n/a
20	chr9:100615357-100615407	NT2-D1	testis:	n/a
21	chr9:100617710-100617760	Jurkat	blood:	n/a
22	chr9:100613647-100613697	MCF-7	breast:	n/a
23	chr9:100615201-100615251	BJ	skin:	n/a
24	chr9:100617999-100618049	T-47D	breast:	n/a
25	chr9:100618041-100618091	PrEC	prostate:	n/a
26	chr9:100615796-100615846	GM12878	blood:	n/a
27	chr9:100617999-100618049	HEEpiC	esophagus:	n/a
28	chr9:100614879-100614929	GM12891	blood:	n/a
29	chr9:100614879-100614929	Jurkat	blood:	n/a
30	chr9:100615244-100615294	Hepatocyte	liver:	n/a
31	chr9:100615084-100615134	HEK293	kidney:	embryo
32	chr9:100614879-100614929	AG09319	gingival:	n/a
33	chr9:100615357-100615407	MCF-7	breast:	n/a
34	chr9:100616469-100616519	NHBE	bronchial:	n/a
35	chr9:100615201-100615251	BE2_C	brain:	n/a
36	chr9:100615201-100615251	GM06990	blood:	n/a
37	chr9:100615244-100615294	NHBE	bronchial:	n/a
38	chr9:100615084-100615134	NHDF-neo	bronchial:	n/a
39	chr9:100615357-100615407	HUVEC	blood vessel:	n/a
40	chr9:100615796-100615846	AG10803	skin:	n/a
41	chr9:100615244-100615294	IMR90	lung:	fetal
42	chr9:100616607-100616657	HRCEpiC	kidney:	n/a
43	chr9:100615357-100615407	HL-60	blood:	n/a
44	chr9:100613647-100613697	T-47D	breast:	n/a
45	chr9:100615084-100615134	SK-N-MC	brain:	n/a
46	chr9:100615201-100615251	HCPEpiC	choroid plexus:	n/a
47	chr9:100618041-100618091	H1-hESC	embryonic stem cell:	embryo
48	chr9:100615201-100615251	AG04449	skin:	fetal
49	chr9:100613647-100613697	HL-60	blood:	n/a
50	chr9:100615357-100615407	IMR90	lung:	fetal

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:100614821..100616567-chr9:100616970..100619601,2	MCF-7	breast:
2	chr9:100617184..100619335-chr9:100637041..100639858,3	MCF-7	breast:
3	chr9:100616472..100617973-chr9:100620292..100623040,2	K562	blood:

No data

Variant related genes	Relation type
FOXE1	TF binding region
FOXE1	CpG island
ENSG00000178919	chromatin interactions

Extended variants
information (count: 206 )
Associated
traits (count: 74 )

Variant overlapped rSNPs/rCNVs (count:206 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs550149865	chr9:100613158-100613159	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs117647586	chr9:100613191-100613192	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs3758252	chr9:100613235-100613236	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs552386114	chr9:100613321-100613322	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs571038265	chr9:100613331-100613332	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs7032302	chr9:100613368-100613369	Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs547076720	chr9:100613382-100613383	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs568422719	chr9:100613521-100613522	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs558435069	chr9:100613633-100613634	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs115240813	chr9:100613655-100613656	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs557390119	chr9:100613679-100613680	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs72753506	chr9:100613689-100613690	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs539729813	chr9:100613695-100613696	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs3758251	chr9:100613700-100613701	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs572997390	chr9:100613713-100613714	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs144442167	chr9:100613723-100613724	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs555478760	chr9:100613737-100613738	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs573650584	chr9:100613772-100613773	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs116694708	chr9:100613781-100613782	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs114389587	chr9:100613783-100613784	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs192308206	chr9:100613803-100613804	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs78164573	chr9:100613813-100613814	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs72753507	chr9:100613836-100613837	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs564579305	chr9:100613858-100613859	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs370600040	chr9:100613862-100613863	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs72753508	chr9:100613885-100613886	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs184739970	chr9:100613934-100613935	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs568588867	chr9:100613947-100613948	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs10046805	chr9:100613956-100613957	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs542200	chr9:100613962-100613963	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs551029891	chr9:100613964-100613965	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs542197	chr9:100613965-100613966	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs569290793	chr9:100613973-100613974	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs3758250	chr9:100614001-100614002	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
35	rs558040971	chr9:100614022-100614023	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs566645124	chr9:100614077-100614078	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs534039490	chr9:100614092-100614093	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs189160829	chr9:100614135-100614136	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs3758249	chr9:100614140-100614141	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs55917248	chr9:100614153-100614154	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs10983975	chr9:100614188-100614189	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs35778541	chr9:100614219-100614220	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs76376939	chr9:100614220-100614221	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs66806500	chr9:100614221-100614222	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs184690826	chr9:100614229-100614230	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs4743137	chr9:100614232-100614233	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs4743138	chr9:100614296-100614297	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs111846096	chr9:100614331-100614332	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs141622703	chr9:100614337-100614338	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs189715084	chr9:100614383-100614384	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:74)

Disease	PMID	Source
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Leukemia	18688285	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	21251322	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Bipolar disorder	18458673	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Biliary cancer	19435499	CNVD
small cell lung cancer	20016488	CNVD
Intracranial aneurysm	16715129	CNVD
Cardiac fibroma	18329553	CNVD
Breast cancer	17133270	CNVD
Basal cell nevus syndrome	21572526	CNVD
Mental retardation	19951919	CNVD
Retinoblastoma	22278416	CNVD
9q22.3 microdeletion syndrome	22283845	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
overgrowth syndrome	16570072	CNVD
Neurodevelopmental disorder	22521361	CNVD
Nicotine dependence	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:463 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:100611600-100614000	Weak transcription	Pancreas	Pancrea
2	chr9:100613400-100613600	Flanking Bivalent TSS/Enh	Primary T helper naive cells fromperipheralblood	blood
3	chr9:100613400-100613600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr9:100613400-100613600	Bivalent/Poised TSS	Right Ventricle	heart
5	chr9:100613400-100613800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
6	chr9:100613400-100613800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
7	chr9:100613400-100613800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
8	chr9:100613400-100613800	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr9:100613400-100613800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr9:100613400-100614000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr9:100613400-100614000	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
12	chr9:100613400-100614000	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
13	chr9:100613400-100614000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
14	chr9:100613400-100615400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
15	chr9:100613400-100615600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
16	chr9:100613400-100615600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
17	chr9:100613400-100615600	Bivalent Enhancer	Spleen	Spleen
18	chr9:100613400-100618800	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr9:100613600-100613800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
20	chr9:100613600-100613800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
21	chr9:100613600-100613800	Flanking Bivalent TSS/Enh	NHEK	skin
22	chr9:100613600-100614000	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr9:100613600-100614000	Bivalent/Poised TSS	HMEC	breast
24	chr9:100613600-100615000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
25	chr9:100613600-100615000	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
26	chr9:100613600-100615000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
27	chr9:100613600-100615200	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
28	chr9:100613600-100618000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
29	chr9:100613800-100614000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
30	chr9:100613800-100614000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr9:100613800-100614000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
32	chr9:100613800-100614000	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
33	chr9:100613800-100614000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr9:100613800-100614000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
35	chr9:100613800-100614000	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
36	chr9:100613800-100614000	Bivalent Enhancer	Brain Germinal Matrix	brain
37	chr9:100613800-100614000	Bivalent Enhancer	Fetal Intestine Small	intestine
38	chr9:100613800-100614000	Flanking Bivalent TSS/Enh	Stomach Smooth Muscle	stomach
39	chr9:100613800-100614000	Bivalent Enhancer	NHDF-Ad	bronchial
40	chr9:100613800-100614000	Bivalent/Poised TSS	NHEK	skin
41	chr9:100613800-100614200	Flanking Bivalent TSS/Enh	IMR90 fetal lung fibroblasts Cell Line	lung
42	chr9:100613800-100614200	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr9:100613800-100614200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
44	chr9:100613800-100614200	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
45	chr9:100613800-100614200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr9:100613800-100614200	Flanking Bivalent TSS/Enh	Esophagus	oesophagus
47	chr9:100613800-100614200	Bivalent Enhancer	Gastric	stomach
48	chr9:100613800-100614400	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
49	chr9:100613800-100614600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
50	chr9:100613800-100614600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links